Febuxostat vs allopurinol: real-world cardiovascular safety

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1762卷 / 1期
关键词：
D O I：
10.1007/s40278-019-64745-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [31] Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis
    Gao, Linggen
    Wang, Bin
    Pan, Ying
    Lu, Yan
    Cheng, Rui
    CLINICAL CARDIOLOGY, 2021, 44 (07) : 907 - 916
  • [32] Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
    Bai, Yang
    Wu, Bin
    Gou, Liangwen
    Fang, Zhenwei
    Xu, Ting
    Zhang, Tiejun
    Li, Yuwen
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [33] Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
    Zhang, Shengzhao
    Xu, Ting
    Shi, Qingyang
    Li, Sheyu
    Wang, Ling
    An, Zhenmei
    Su, Na
    FRONTIERS IN MEDICINE, 2021, 8
  • [34] Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis
    Deng, Jian-Hao
    Zhang, Jia-Xing
    CLINICAL CARDIOLOGY, 2022, 45 (07) : 685 - 686
  • [35] Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
    Choi, Hyon
    Neogi, Tuhina
    Stamp, Lisa
    Dalbeth, Nicola
    Terkeltaub, Robert
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) : 1702 - 1709
  • [36] Cardiovascular Safety of Febuxostat Reply
    White, William B.
    Gunawardhana, Lhanoo
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (16): : 1584 - 1584
  • [37] Febuxostat cardiovascular safety revisited
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (01) : 3 - 3
  • [38] Up-Titration of Allopurinol in the Febuxostat vs. Allopurinol Streamlined Trial (FAST)
    Jennings, Claudine
    Mackenzie, Isla S.
    Flynn, Rob
    Ford, Ian
    Nuki, George
    MacDonald, Thomas M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 424 - 425
  • [39] Experiments vs real-world studies
    不详
    ANNALS OF BOTANY, 2017, 120 (04) : V - V
  • [40] Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
    MacDonald, Thomas M.
    Ford, Ian
    Nuki, George
    Mackenzie, Isla S.
    De Caterina, Raffaele
    Findlay, Evelyn
    Hallas, Jesper
    Hawkey, Christopher J.
    Ralston, Stuart
    Walters, Matthew
    Webster, John
    McMurray, John
    Ruiz, Fernando Perez
    Jennings, Claudine G.
    BMJ OPEN, 2014, 4 (07):
12345